Evolve Private Wealth’s Clorox CLX Stock Holding History

Evolve Private Wealth’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,843	Closed	-$502K	–	1038
2026 Q1	$502K	Buy	4,843 +1,981	+69%	+$225K	0.03%	578
2025 Q4	$289K	Buy	+2,862	New	+$311K	0.02%	742

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Evolve Private Wealth's CLX Position: Q2 2026 in Review

Evolve Private Wealth sold out of Clorox (CLX) in Q2 2026, closing a stake of 4,843 shares — an estimated $502K sold.

Evolve Private Wealth first reported a position in CLX in Q4 2025 and held it in 2 quarters. The position peaked at $502K in Q1 2026. 1,044 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

Evolve Private Wealth reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
Evolve Private Wealth sold 4,843 Clorox shares in Q2 2026, an estimated $502K.
Evolve Private Wealth first reported a position in Clorox in Q4 2025 and held it in 2 quarters.
Evolve Private Wealth's Clorox position peaked at $502K in Q1 2026.
1,044 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.